J P M O R G A N North America Equity Research 10 June 2026 Illumina, Inc. Upgrading to Overweight on a Sticky Clinical User Base and Test Volume Runway Following Customer Survey; PT to $185 Marta Nazarovets Zaremba (1-212) 622-6046 marta.zaremba@jpmchase.com Jaden Rismay (1-212) 622-8479 jaden.rismay@jpmchase.com Sebastian Sandler (1-212) 622-8464 sebastian.sandler@jpmchase.com J.P. Morgan Securities LLC Illumina (ILMN) has been one of the most highly debated stocks in our space over the last year and a hal ...